Lexicon Pharmaceuticals, Inc. (LXRX) stock
LXRXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 5/3087% above fair value
$1.72−0.06 (-3.37%)
Close on Nov 18, 2026Market cap $765.32MP/E –Yield –
Lexicon Pharmaceuticals operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
Lexicon Pharmaceuticals's operating cash flow for the twelve months ending Jun 30, 2026 was -$64.99M. For fiscal 2025 it was -$67.85M. The highest annual figure on record is $184.78M in fiscal 2015.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$67.85M | – |
| FY2024 | Dec 31, 2024 | -$178.78M | – |
| FY2023 | Dec 31, 2023 | -$161.90M | – |
| FY2022 | Dec 31, 2022 | -$88.85M | – |
| FY2021 | Dec 31, 2021 | -$87.02M | – |
| FY2020 | Dec 31, 2020 | -$142.97M | -225.6% |
| FY2019 | Dec 31, 2019 | $113.81M | – |
| FY2018 | Dec 31, 2018 | -$148.61M | – |
| FY2017 | Dec 31, 2017 | -$185.39M | – |
| FY2016 | Dec 31, 2016 | -$175.63M | -195.0% |
| FY2015 | Dec 31, 2015 | $184.78M | – |
| FY2014 | Dec 31, 2014 | -$75.62M | – |
| FY2013 | Dec 31, 2013 | -$91.08M | – |
| FY2012 | Dec 31, 2012 | -$94.46M | – |
| FY2011 | Dec 31, 2011 | -$87.94M | – |
| FY2010 | Dec 31, 2010 | -$82.37M | – |
| FY2009 | Dec 31, 2009 | -$89.02M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$9.19M | -154.1% |
| Q1 FY2026 | Mar 31, 2026 | -$14.73M | – |
| Q4 FY2025 | Dec 31, 2025 | -$17.23M | – |
| Q3 FY2025 | Sep 30, 2025 | -$23.83M | – |
| Q2 FY2025 | Jun 30, 2025 | $16.99M | – |
| Q1 FY2025 | Mar 31, 2025 | -$43.78M | – |
| Q4 FY2024 | Dec 31, 2024 | -$21.49M | – |
| Q3 FY2024 | Sep 30, 2024 | -$53.62M | – |
| Q2 FY2024 | Jun 30, 2024 | -$48.54M | – |
| Q1 FY2024 | Mar 31, 2024 | -$55.13M | – |
| Q4 FY2023 | Dec 31, 2023 | -$50.55M | – |
| Q3 FY2023 | Sep 30, 2023 | -$41.62M | – |
| Q2 FY2023 | Jun 30, 2023 | -$38.12M | – |
| Q1 FY2023 | Mar 31, 2023 | -$31.61M | – |
| Q4 FY2022 | Dec 31, 2022 | -$21.57M | – |
| Q3 FY2022 | Sep 30, 2022 | -$19.44M | – |
| Q2 FY2022 | Jun 30, 2022 | -$24.42M | – |
| Q1 FY2022 | Mar 31, 2022 | -$23.42M | – |
| Q4 FY2021 | Dec 31, 2021 | -$22.83M | – |
| Q3 FY2021 | Sep 30, 2021 | -$17.15M | – |
| Q2 FY2021 | Jun 30, 2021 | -$21.88M | – |
| Q1 FY2021 | Mar 31, 2021 | -$25.16M | – |
| Q4 FY2020 | Dec 31, 2020 | -$34.24M | – |
| Q3 FY2020 | Sep 30, 2020 | -$40.38M | -121.2% |
| Q2 FY2020 | Jun 30, 2020 | -$46.30M | – |
| Q1 FY2020 | Mar 31, 2020 | -$22.05M | – |
| Q4 FY2019 | Dec 31, 2019 | -$24.37M | – |
| Q3 FY2019 | Sep 30, 2019 | $190.70M | – |
| Q2 FY2019 | Jun 30, 2019 | -$26.90M | – |
| Q1 FY2019 | Mar 31, 2019 | -$25.62M | – |
| Q4 FY2018 | Dec 31, 2018 | -$27.13M | – |
| Q3 FY2018 | Sep 30, 2018 | -$22.18M | – |
| Q2 FY2018 | Jun 30, 2018 | -$52.52M | – |
| Q1 FY2018 | Mar 31, 2018 | -$46.78M | – |
| Q4 FY2017 | Dec 31, 2017 | -$33.71M | – |
| Q3 FY2017 | Sep 30, 2017 | -$33.96M | – |
| Q2 FY2017 | Jun 30, 2017 | -$32.23M | – |
| Q1 FY2017 | Mar 31, 2017 | -$85.50M | – |
| Q4 FY2016 | Dec 31, 2016 | -$48.79M | – |
| Q3 FY2016 | Sep 30, 2016 | -$35.22M | – |
See a number that looks wrong?